Related Experiment Video
Updated: May 27, 2026

Mass Spectrometry and Luminogenic-based Approaches to Characterize Phase I Metabolic Competency of In Vitro Cell Cultures
Published on: March 28, 2017
How is sesamin metabolised in the human liver to show its biological effects?
Kaori Yasuda1, Toshiyuki Sakaki
1Toyama Prefectural University, Department of Biotechnology, Faculty of Engineering, 5180 Kurokawa, Imizu, Toyama 939-0398, Japan.
Introduction:
Sesamin is a major lignan found in sesame and is known to have various biological effects. Some of these biological effects occur following its metabolic conversion to corresponding catechols and, therefore, the study of sesamin metabolism is quite important. There is currently a need to identify the enzymes responsible for metabolism of sesamin so that scientists will be more able to predict sesamin-drug interactions.
Areas Covered:
The authors reviewed all the published literature with a focus on papers that dealt with metabolism of sesamin by drug-metabolising enzymes in rat and/or human liver, such as cytochrome P450 and UDP-glucuronosyltransferase. The article also reviews papers that dealt with the inhibition of enzymes by sesamin including drug-metabolising enzymes and other physiologically important enzymes. Additionally, the authors discuss the species-based differences in the metabolism of sesamin between rats and humans.
Expert Opinion:
A remarkable species-based difference was found in sesamin metabolism between humans and other animals; thus, it is very important that precautions are taken when predicting the physiological effects in humans from animal data. A mechanism-based inhibition of human CYP2C9 by sesamin was recently discovered, suggesting that it is important to evaluate the interaction between sesamin and drugs that are mainly metabolised by CYP2C9. Furthermore, further analysis of sesamin and episesamin and their molecular mechanisms are needed to make better use of sesamin supplements.
Related Concept Videos
Drug Metabolism: Phase II Reactions
Effect of Hepatic Disease on Pharmacokinetics: Active Drug, Metabolite and Fraction of Metabolized Drug
Phase I Reactions: Oxidation of Aliphatic and Aromatic Carbon-Containing Systems
Oxidation reactions are fundamental in aromatic carbon-containing systems. An example is the hydroxylation of phenobarbital, a process that transforms it into...
Effect of Hepatic Disease on Pharmacokinetics: Pathophysiologic Assessment and Liver Function Test
First Pass Effect
Depending on the route of administration, drugs can be metabolized in the liver, intestine, lungs, and vasculature. Orally administered drugs are first absorbed through the...
Factors Affecting Drug Biotransformation: Biological
Species differences: Variations in enzyme systems across species can cause disparities in drug metabolism. For instance, humans may metabolize certain drugs faster than rodents, altering therapeutic effects.
Strain differences: Genetic variations within a species can result in differing enzyme activity, impacting drug response and toxicity. For example, some mouse strains may...
